Skin barrier regeneration

Skin barrier regeneration refers to the process by which the skin restores its structural and functional integrity following injury or disruption. The epidermal barrier is primarily maintained by a stratified squamous epidermis, with basal stem cells (keratinocytes) self-renewing and differentiating outward to replenish lost or damaged layers. The skin barrier involves physical structures (stratum corneum, tight junctions), biochemical defenses (antimicrobial peptides, lipids including ceramides), immunoregulation, and the unique acidic mantle. Disruption of this barrier is implicated in diseases such as atopic dermatitis and psoriasis. The restoration process depends on keratinocyte migration, differentiation (involving factors like CDK9), and active biochemical modulation, including mitochondrial health and sphingolipid metabolism. Therapies focus on restoring the lipid matrix (especially ceramides), modulating inflammation, and supporting cellular energy homeostasis. In summary, “skin barrier regeneration” is a vital process rather than a discrete therapeutic target or receptor molecule. It integrates multiple biological systems and molecular pathways. For structured pharmacological or biomedical data, focus would need to shift to specific molecular effectors (e.g., “filaggrin,” “ceramide synthase,” “CDK9,” “keratinocyte growth factor receptor”).

Other names

Skin barrier repairSkin regenerationEpidermal regeneration

Restoration of lipid matrix (emollients/ceramides); Reduction of inflammation (ceramide analogs); Modulation of mitochondrial function (SIRT3 activators)